Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data

Published:2023-09 Issue: Volume:Volume 16 Page:2525-2536
ISSN:1178-7015
Container-title:Clinical, Cosmetic and Investigational Dermatology
language:en
Short-container-title:CCID

Author:

Martora Fabrizio^ORCID,Scalvenzi Massimiliano,Battista Teresa,Fornaro Luigi,Potestio Luca^ORCID,Ruggiero Angelo^ORCID,Megna Matteo

Publisher

Informa UK Limited

Subject

Dermatology

Reference92 articles.

1. The Hidradenitis Suppurativa (HS) “Multidisciplinary Unit”: a rationale and practical proposal for an organised clinical approach

2. A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa?

3. Hidradenitis suppurativa

4. Reply to: ‘‘Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis”

5. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature;Medicina;2024-09-06

2. Effect of adalimumab treatment on inflammatory and hematological parameters in patients with Hidradenitis suppurativa;Cutaneous and Ocular Toxicology;2024-08-11

3. Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis;Experimental Dermatology;2024-07

4. Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-05

5. Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3